PDE2/PDE10-IN-1 is primarily used in research settings to study the roles of phosphodiesterase 2 (PDE2) and phosphodiesterase 10 (PDE10) enzymes in cellular signaling pathways. It serves as a dual inhibitor, helping scientists understand the physiological and pathological functions of these enzymes, particularly in the central nervous system. This compound is valuable in exploring potential therapeutic strategies for neurological disorders such as schizophrenia, Parkinson’s disease, and Huntington’s disease, where PDE2 and PDE10 activity is implicated. Additionally, it aids in investigating cognitive processes, memory, and learning, as these enzymes regulate cyclic nucleotide signaling, which is critical for neuronal function. Its application extends to drug discovery efforts aimed at developing targeted treatments for psychiatric and neurodegenerative conditions.